Efficacy of intravenous liposomal amphotericin B (AmBisome) against coccidioidal meningitis in rabbits.
about
Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy?Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis.The public health impact of coccidioidomycosis in Arizona and California.Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.Pharmacokinetic-pharmacodynamic comparison of amphotericin B (AMB) and two lipid-associated AMB preparations, liposomal AMB and AMB lipid complex, in murine candidiasis models.Coccidioidal meningitis.Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis modelCombating opportunistic infections: coccidioidomycosis.Management of intracranial fungal infections in patients with haematological malignancies.Comparison of the physicochemical, antifungal, and toxic properties of two liposomal amphotericin B products.Experimental animal models of coccidioidomycosis.Amphotericin B and coccidioidomycosis.CNS pharmacokinetics of antifungal agents.High-dose weekly AmBisome antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic studyCerebral aspergillosis: tissue penetration is the key.Treatment of endemic mycoses.Coccidioidal meningitis complicated by central nervous system vasculitis in a patient with leukemia.Central nervous system toxicity associated with liposomal amphotericin B therapy for cutaneous leishmaniasis.Reflections on the approach to treatment of a mycologic disaster.Amphotericin B transfer to CSF following intravenous administration of liposomal amphotericin B.Tissue pharmacokinetics and pharmacodynamics of AmBisome® (L-AmBis) in uninfected and infected animals and their effects on dosing regimens.Disseminated coccidioidomycosis presenting with intramedullary spinal cord abscesses: Management challenges.Coccidioidomycosis with cerebral and cerebellar granulomas.Preclinical identification of vaccine induced protective correlates in human leukocyte antigen expressing transgenic mice infected with Coccidioides posadasii.Cerebrospinal Fluid (1,3)-Beta-d-Glucan Testing Is Useful in Diagnosis of Coccidioidal Meningitis.Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis.Comparative efficacies of lipid-complexed amphotericin B and liposomal amphotericin B against coccidioidal meningitis in rabbits.Experimental central nervous system aspergillosis therapy: efficacy, drug levels and localization, immunohistopathology, and toxicity.Visual changes in a 4-year-old.Liposomal Amphotericin B as Monotherapy in Relapsed Coccidioidal Meningitis.
P2860
Q26740363-3CB32D36-BEA7-404D-801B-CFA4F7A70613Q28279473-70D05199-0743-4EDC-988D-BC7E3EFDD3ABQ30151881-5C0CF4C7-91ED-4A1A-8C69-B2B6FF1BE887Q34194528-842752AD-2570-4454-B048-09F36D04ECB9Q34228354-17BA3CCB-6605-4C9C-83B0-7D2324E0F292Q34352186-34266406-F6BE-4134-A081-BE41AAD56E11Q34563038-28D35295-8741-4462-B8C3-24793598FF24Q34680675-6E6C0071-B731-43A9-B340-1DE335B77FA1Q35680578-18D13BB4-9943-46B0-AF7F-2BB4E57DEE66Q36286439-E5DD0E51-C8A0-4BF4-AD29-66C7000D756FQ36422661-BCDEEA7D-9ECA-4E62-85B1-CD01CEC9886EQ36754015-55C3AA95-0F15-41CF-A2E3-18100D71F06CQ36826922-AAD752D2-187F-4C27-A396-4B1A0BE9B437Q36909333-44E6EC43-E2CC-498F-9995-46A04266D1A2Q37016279-0F087ACF-F692-4C1D-AE5E-F2792EA85563Q37405288-CD650EB3-62D3-4597-9EDB-452F84A472A0Q37729998-09558C84-0DFE-48DA-9755-EF36CEC54724Q37731835-CC713B1C-BDF0-4523-AC61-5C0A4B69A802Q37860768-5D422ED2-4D9D-4688-95C8-318135964E62Q39767419-F8A0E3F0-825B-4420-8CA8-4B7B98F88CE4Q40197617-0225EA19-9FA4-4317-B6F4-56CA73896AECQ40222438-E95A026E-8D10-4962-8DC8-88239DC1D472Q40267928-06363A47-A1C8-4AD6-825F-3A8372F79B25Q40475938-C4EA6718-F695-4E61-B840-8CA54C1E270DQ40542327-1AD2DB41-000B-4DBE-B1F5-3B289F4F7A8FQ40564160-FD4A7F72-0D8C-4E45-B532-6F7722D1C5D3Q40667866-559F749F-A52A-401C-9B67-58E4B1D01A73Q42211382-E2186E50-61D1-402E-A1F2-3D1F9FA19646Q42217419-49EDF0CC-DE39-40C1-80C6-3B64A752203CQ46262191-98B9184F-AF25-45E2-8A29-B62DF1DBA883Q50013433-84F5557D-9509-437C-A2A7-94562625EFAC
P2860
Efficacy of intravenous liposomal amphotericin B (AmBisome) against coccidioidal meningitis in rabbits.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Efficacy of intravenous liposo ...... dioidal meningitis in rabbits.
@en
Efficacy of intravenous liposomal amphotericin B
@nl
type
label
Efficacy of intravenous liposo ...... dioidal meningitis in rabbits.
@en
Efficacy of intravenous liposomal amphotericin B
@nl
prefLabel
Efficacy of intravenous liposo ...... dioidal meningitis in rabbits.
@en
Efficacy of intravenous liposomal amphotericin B
@nl
P2093
P2860
P1476
Efficacy of intravenous liposo ...... dioidal meningitis in rabbits.
@en
P2093
David A Stevens
Demosthenes Pappagianis
Karl V Clemons
Paul L Williams
Raymond A Sobel
P2860
P304
P356
10.1128/AAC.46.8.2420-2426.2002
P407
P577
2002-08-01T00:00:00Z